851799-54-7

Upstream product

• 851799-53-6 (2-methoxyethyl)[2-(4-nitrophenoxy)ethyl]amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 100-02-7 4-nitro-phenol 
• 518031-72-6 C₁₀H₁₄N₂O₄ 
• 13288-06-7 1-(2-bromoethoxy)-4-nitrobenzene 

Downstream Products

• 851799-55-8 N-[2-(4-aminophenoxy)ethyl](tert-butoxy)-N-(2-methoxyethyl)-carboxamide 
• 851799-57-0 N-(2-{4-[2-amino-3-cyano-4-(4-methoxyphenyl)pyrrolyl]phenoxy}-ethyl)(tert-butoxy)-N-(2-methoxyethyl)carboxamide 
• 540757-24-2 (2-{4-[4-amino-5-(4-methoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]-phenoxy}ethyl)(2-methoxyethyl)amine 
• 851799-56-9 (tert-butoxy)-N(2-methoxyethyl)-N-[2-(4-{[2-(4-methoxyphenyl)-2-oxoethyl]amino}phenoxy)ethyl]carboxamide 

Relevant academic research and scientific papers

METHODS OF USING SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS

Methods of using semi-synthetic glycopeptides of formula I-XIV having antibacterial activity are described.

PROTECTION OF TISSUES AND CELLS FROM CYTOTOXIC EFFECTS OF IONIZING RADIATION BY ABL INHIBITORS

Pre-treatment with one or more compounds of formula (I), as described herein, protects normal cells from the toxic side effects of ionizing radiation. Administration of one or more radioprotective compounds of formula (I) to a patient prior to anticancer